VB
Therapeutic Areas
Milestone Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CARDAMYST™ (Etripamil) Nasal Spray | Paroxysmal Supraventricular Tachycardia (PSVT) in Adults | Approved |
| Etripamil Nasal Spray | Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR) in Adults | Phase 3 |
Leadership Team at Milestone Pharmaceuticals
JO
Joseph Oliveto
President & CEO
AH
Amit Hasija
CFO and EVP of Corporate Development
DB
David B. Bharucha
Chief Medical Officer
LM
Lorenz Muller
Chief Commercial Officer
JN
Jeff Nelson
Chief Operating Officer
DS
David Sandoval
General Counsel and Chief Compliance Officer
DE
Debbie Everidge
VP of Information Technology
RG
Roshan Girglani
VP of Marketing
AH
Anita Holz
VP Head of Medical Affairs
JJ
John Jackimiec
VP of Market Access